Didanosine adverse reactions: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) |
||
| Line 11: | Line 11: | ||
* [[Lactic acidosis]]/severe [[hepatomegaly]] with [[steatosis]] | * [[Lactic acidosis]]/severe [[hepatomegaly]] with [[steatosis]] | ||
* Hepatic toxicity | * [[Hepatotoxicity|Hepatic toxicity]] | ||
* Non-cirrhotic [[portal hypertension]] | * Non-cirrhotic [[portal hypertension]] | ||
Latest revision as of 05:52, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Adverse Reactions
The following adverse reactions are discussed in greater detail in other sections[1]:
- Lactic acidosis/severe hepatomegaly with steatosis
- Non-cirrhotic portal hypertension
- Retinal changes and optic neuritis
References
Adapted from the FDA Package Insert.